Crossmark

Risk assessment models for potential use in the emergency department have lower predictive ability in older patients compared to the middle-aged for short-term mortality – a retrospective cohort study

Crossref DOI link: https://doi.org/10.1186/s12877-019-1154-7

Published Online: 2019-05-16

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Schultz, Martin http://orcid.org/0000-0002-1259-645X
Rasmussen, Line Jee Hartmann

Carlson, Nicolas

Hasselbalch, Rasmus Bo

Jensen, Birgitte Nybo

Usinger, Lotte

Eugen-Olsen, Jesper

Torp-Pedersen, Christian

Rasmussen, Lars Simon

Iversen, Kasper Karmark
License Information

Text and Data Mining valid from 2019-05-16

Version of Record valid from 2019-05-16
More Information

Article History

Received: 12 September 2018

Accepted: 9 May 2019

First Online: 16 May 2019

Ethics approval and consent to participate

: The TRIAGE studies were approved by Danish Patient Safety Authority instead of patient consent, in accordance with Danish legislation. All processing of personal data followed national guidelines and was approved by the Danish Data Protection Agency. Both TRIAGE studies were presented to the regional independent ethics committee, who decided that no consent were required in accordance with Danish law.

: Not applicable.

: MS and LJHR have received funding for travel from ViroGates A/S. JE-O is named as an inventor in patents for the use of suPAR as a prognostic biomarker. The patents are owned by Copenhagen University Hospital, Amager and Hvidovre, Denmark, and are licensed to ViroGates A/S. JE-O is a co-founder, shareholder, and CSO of ViroGates A/S. The remaining authors have no conflicts of interest to declare.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below